Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat

Phytotherapy Research

Volumn 22, Issue 5, 2008, Pages 597-604

  Zheng, Ming ^a   Qu, Linhai ^a   Lou, Yijia ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apoptosis; Cognitive impairment; Icariin; Ischemia reperfusion; Lipid peroxidation; Panax notoginseng saponin

Indexed keywords

DIHYDROERGOTOXINE MESILATE; ICARIIN; NITROPRUSSIDE SODIUM; PANAX NOTOGINSENG EXTRACT; SUPEROXIDE DISMUTASE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VISCOSITY; BRAIN ISCHEMIA; CELL PROTECTION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING DISORDER; LIPID PEROXIDATION; MALE; MAZE TEST; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; SHAM PROCEDURE; TASK PERFORMANCE;

ANIMALS; APOPTOSIS; BLOOD VISCOSITY; BRAIN; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; FLAVONOIDS; HIPPOCAMPUS; IN SITU NICK-END LABELING; LIPID PEROXIDATION; MALE; MAZE LEARNING; MOLECULAR STRUCTURE; NEURONS; OXIDATIVE STRESS; PANAX NOTOGINSENG; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SAPONINS; SUPEROXIDE DISMUTASE;

PANAX NOTOGINSENG; RATTUS;

EID: 44149119320     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2276     Document Type: Article

References (38)

1. Bast A, Haenen GR, Doelman GJ. 1991. Oxidants and antioxidants: state of art. Am J Med 91: 23-28.
2. - of polysaccharides and decoction of Epimedium brericorum. Northwest Pharm J 2: 79-82.
3. Borbely K. 2002. Pathophysiology of cerebrovascular disorders: PET imaging of the brain. Orv Hetil 143: 2173-2182.
4. Cai J, Du J, Huang JS, Lin QC. 2003. Clinical effect of the principle of tonifying-kidney, invigorating-spleen, nourishing and activating-blood on patients with vascular dementia. Chin J Clin Rehabil 7: 4251-4253.
5. Cantuti CI, Shukitt-Hale B, Joseph JA. 2000. Neurobehavioural aspects of antioxidants in aging. Int J Dev Neurosci 18: 367-381.
6. Cicero AFG, Bandieri E, Arletti R. 2000. Orally administered Panax notoginseng influence on rat spontaneous behaviour. J Ethnopharmacol 73: 387.
7. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. 2000. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10: 95-112.
8. del Zoppo GJ, Wagner S, Tagaya M. 1997. Trends and future developments in the pharmacological treatment of acute ischemic stroke. Drugs 54: 9-38.
9. Gonzalez-Scarano F, Baltuch G. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219-240.
10. Grech ED, Dodd NJF, Lackson MJ, Morrison WL, Faragher EB, Ramsdale DR. 1996. Evidence for free radical generation after primary percutaneous transluminal angioplasty recanalization in acute myocardial infarction. Am J Cardiol 77: 122-127.
11. Han J, Zhong JJ. 2002. High density cell culture of Panax notoginseng for production of ginseng saponin and polysaccharide in an airlift bioreactor. Biotechnol Lett 24: 1927-1930.
12. Ji H, Liu K, Li SP. 2000. Effect of HEF on osteoporosis induced by retinoic acid in male rats. J Chin Pharm Univ 31: 222-225.
13. Jiang YN, Mo HY, Chen JM. 2002. Effect of Epimedium total flavonoids phytosomes on preventing and treating bone-loss of ovariectomized rats. China J Chin Mater Med 27: 221-224.
14. Kiyota Y, Miyamoto M, Nagaoka A. 1991. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. Brain Res 538: 296-302.
15. Kono Y. 1978. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186(1): 189-195.
16. Launer LJ, Ross GW, Petrovitch H et al. 2000. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21: 49-55.
17. Li WK, Lin X, Luo CN, Xia PG. 1995. Recent domestic research on icariin. J Northwest Pharm (Xi Bei Yao Xue Za Zhi) 10: 138-140.
18. Ling HY, Lou YJ. 2005. Total flavones from Elsholtzia blanda reduce infarct size during acute myocardial ischemia by inhibiting myocardial apoptosis in rats. J Ethnopharmacol 101: 169-175.
19. Liu J, Lou YJ. 2004. Determination of icariin and metabolites in rat serum by capillary zone electrophoresis: rat pharmacokinetic studies after administration of icariin. J Pharm Biomed Anal 36: 365-370.
20. Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 193(1): 265-275.
21. Miyamoto O, Tamae K, Kasai H et al. 2003. Suppression of hyperemia and DNA oxidation by indomethacin in cerebral ischemia. Eur J Pharmacol 459: 179-186.
22. Osawa M, Maruyama S. 1985. Effects of TCV-3B(Vinpocetine) on blood viscosity in ischemic cerebrovascular diseases. Ther Hung 33: 7-12.
23. Pulsinelli WA, Jacewicz M, Levy DE, Petito CK, Plum F. 1997. Ischemic brain injury and the therapeutic window. Ann N Y Acad Sci 835: 187-193.
24. Qu ZQ, Xie ZG, Wang NP, Pao YP, Zhong ZG. 2005. Experimental studies on anti-aging actions of total saponins of Radix Notoginseng. J Guangdong Univ TCM 22: 130-133.
25. Reiter RJ. 1995. Oxidative processes and antioxidative defence mechanisms in the aging brain. FASEB J 9: 526-533.
26. Sakaguchi M, Koseki M, Wakamatsu M, Matsumura E. 2003. Effects of beta-casomorphin-5 on passive avoidance response in mice. Biosci Biotechnol Biochem 67: 2501-2504.
27. Schmidt-Kastner R, Freund TF. 1991. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40: 599-636.
28. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. 1997. Brain infarction and the clinical expression of Alzheimer disease: the nun study. JAMA 277: 813-817.
29. Tohgi H, Yonezawa H, Takahashi S et al. 1998. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 40: 131-137.
30. Wallin A, Blennow K. 1993. Heterogeneity of vascular dementia: mechanisms and subgroup. J Geriatr Psychiatry Neurol 6: 177-188.
31. Wang R, Yang QF, Tang YP et al. 2000. Establishing of the imitative vascular dementia rat model and the preliminary study on the preventive and treating effects of TCM preparation 9602 on the disease. J Beijing Univ TCM 23(5): 30-32.
32. 2 in vitro. Pharmacol Res 52: 174-182.
33. Wang ZQ, Lou YJ. 2004. Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. Eur J Pharmacol 504: 147-153.
34. Wang ZQ, Zhang XN, Lou YJ et al. 2007. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience 145(3): 911-922.
35. Xiao XF, Zheng M, Qu LH, Lou YJ. 2005. Effects of icariin combined with the Panax notoginseng saponins on behavior and acetylcholinesterase activity induced by β-amyloid peptide 25-35 lateral ventricle injection in rats. Chin J MAP 22: 178-181.
36. Xu HB, Huang ZQ. 2007. Vasorelaxant effects of icariin on isolated canine coronary artery. J Cardiovasc Pharmacol 49: 207-213.
37. - of epimedium. Chin J Sports Med 22: 434-435.
38. Zou JM, Meng J, Yang ZH, Long ZX, Shi XJ. 2002. Pharmacokinetic studies of icariin in Chinese formulated medicine. Chin Tradit Herbal Drugs 33: 55-58.